Should Pfizer’s AstraZeneca Bid Worry the U.K.?

Should Pfizer’s AstraZeneca Bid Worry the U.K.? Play

May 5 (Bloomberg) -- Mark Schoenebaum, head of healthcare research at ISI Group, examines Pfizer’s bid for AstraZeneca as the U.K. government calls for an inquiry into the potential deal on Bloomberg Television’s “Bloomberg Surveillance.”

  • On Air Now

    CGI America: Denver Watch Now

  • Next

    Political Capital with Al Hunt

(enter your email)
(enter up to 5 email addresses, separated by commas)

Max 250 characters

blog comments powered by Disqus